Cargando…
Aniline-containing derivatives of parthenolide: Synthesis and anti-chronic lymphocytic leukaemia activity
Parthenolide exhibits anti-leukaemia activity, whilst its synthetic modification to impart improve drug-like properties, including 1,4-conjugate addition of primary and secondary amines, have previously been used, 1,4-addition of aniline derivatives to parthenolide has not been fully explored. A pro...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pergamon Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695678/ https://www.ncbi.nlm.nih.gov/pubmed/33299257 http://dx.doi.org/10.1016/j.tet.2020.131631 |
_version_ | 1783615242017701888 |
---|---|
author | Quy, Alex S. Li, Xingjian Male, Louise Stankovic, Tatjana Agathanggelou, Angelo Fossey, John S. |
author_facet | Quy, Alex S. Li, Xingjian Male, Louise Stankovic, Tatjana Agathanggelou, Angelo Fossey, John S. |
author_sort | Quy, Alex S. |
collection | PubMed |
description | Parthenolide exhibits anti-leukaemia activity, whilst its synthetic modification to impart improve drug-like properties, including 1,4-conjugate addition of primary and secondary amines, have previously been used, 1,4-addition of aniline derivatives to parthenolide has not been fully explored. A protocol for such additions to parthenolide is outlined herein. Reaction conditions were determined using tulipane as a model Michael acceptor. Subsequently, aniline-containing parthenolide derivatives were prepared under the optimised conditions and single crystal X-ray diffraction structures were resolved for three of the compounds synthesised. The synthesised derivatives, along with compounds resulting from a side reaction, were tested for their in vitro anti-leukaemia activity using the chronic lymphocytic leukaemia (CLL) MEC1 cell line. Computational studies with the 2RAM protein structure suggested that the activity of the derivatives was independent of their in silico ability to dock with the Cys38 residue of NF-κB. |
format | Online Article Text |
id | pubmed-7695678 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Pergamon Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-76956782020-12-07 Aniline-containing derivatives of parthenolide: Synthesis and anti-chronic lymphocytic leukaemia activity Quy, Alex S. Li, Xingjian Male, Louise Stankovic, Tatjana Agathanggelou, Angelo Fossey, John S. Tetrahedron Article Parthenolide exhibits anti-leukaemia activity, whilst its synthetic modification to impart improve drug-like properties, including 1,4-conjugate addition of primary and secondary amines, have previously been used, 1,4-addition of aniline derivatives to parthenolide has not been fully explored. A protocol for such additions to parthenolide is outlined herein. Reaction conditions were determined using tulipane as a model Michael acceptor. Subsequently, aniline-containing parthenolide derivatives were prepared under the optimised conditions and single crystal X-ray diffraction structures were resolved for three of the compounds synthesised. The synthesised derivatives, along with compounds resulting from a side reaction, were tested for their in vitro anti-leukaemia activity using the chronic lymphocytic leukaemia (CLL) MEC1 cell line. Computational studies with the 2RAM protein structure suggested that the activity of the derivatives was independent of their in silico ability to dock with the Cys38 residue of NF-κB. Pergamon Press 2020-11-27 /pmc/articles/PMC7695678/ /pubmed/33299257 http://dx.doi.org/10.1016/j.tet.2020.131631 Text en Crown Copyright © 2020 Published by Elsevier Ltd. http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Quy, Alex S. Li, Xingjian Male, Louise Stankovic, Tatjana Agathanggelou, Angelo Fossey, John S. Aniline-containing derivatives of parthenolide: Synthesis and anti-chronic lymphocytic leukaemia activity |
title | Aniline-containing derivatives of parthenolide: Synthesis and anti-chronic lymphocytic leukaemia activity |
title_full | Aniline-containing derivatives of parthenolide: Synthesis and anti-chronic lymphocytic leukaemia activity |
title_fullStr | Aniline-containing derivatives of parthenolide: Synthesis and anti-chronic lymphocytic leukaemia activity |
title_full_unstemmed | Aniline-containing derivatives of parthenolide: Synthesis and anti-chronic lymphocytic leukaemia activity |
title_short | Aniline-containing derivatives of parthenolide: Synthesis and anti-chronic lymphocytic leukaemia activity |
title_sort | aniline-containing derivatives of parthenolide: synthesis and anti-chronic lymphocytic leukaemia activity |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695678/ https://www.ncbi.nlm.nih.gov/pubmed/33299257 http://dx.doi.org/10.1016/j.tet.2020.131631 |
work_keys_str_mv | AT quyalexs anilinecontainingderivativesofparthenolidesynthesisandantichroniclymphocyticleukaemiaactivity AT lixingjian anilinecontainingderivativesofparthenolidesynthesisandantichroniclymphocyticleukaemiaactivity AT malelouise anilinecontainingderivativesofparthenolidesynthesisandantichroniclymphocyticleukaemiaactivity AT stankovictatjana anilinecontainingderivativesofparthenolidesynthesisandantichroniclymphocyticleukaemiaactivity AT agathanggelouangelo anilinecontainingderivativesofparthenolidesynthesisandantichroniclymphocyticleukaemiaactivity AT fosseyjohns anilinecontainingderivativesofparthenolidesynthesisandantichroniclymphocyticleukaemiaactivity |